Skip to content
Screener

KRAKacquisition KRAQ Deferred offering costs

Deferred offering costs at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$200K-33.3%
DeFi Development Corp. logo
DeFi Development Corp.DFDV
$3.36M+2,861%
Alpha Cognition logo
Alpha CognitionACOG
$223.1K
Beneficient logo
BeneficientBENF
$0-100%
CUB
Lionheart HoldingsCUB
$662.88K0.0%
Hitachi logo
HitachiHIT
$170.98K

Segments

By segment

See full
Single$0

Other financials

Income statement

See full
Operating income-$11.0M
Net income-$8.9M
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$824.6K
Total debt$77.4K
Total equity-$19.9M
Total assets$348.0M

Cash flow

See full
Operating cash flow-$669.9K

Valuation

See full
Market cap$432.11M+1.2%
Enterprise value$431.37M

Returns & leverage

See full
Debt / equity-0×
Current ratio7.7×